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Abstract 
 
 In an attempt to isolate and identify proteins that differentially interact with or locate near 
lamin A and progerin, we used a previously described method named BioID (proximity-
dependent biotin identification). This method is based on fusion of a promiscuous E. coli biotin-
protein ligase (BL) to a targeting protein (in this study, lamin A-GFP and progerin-GFP). The 
biotin ligase biotinylates amino residues in proteins that are near-neighbors of the fusion protein. 
To create the fusion proteins, BL was sub-cloned from a pcDNA3.1 MCS-BirA(R118G)-HA 
plasmid donated by Kyle Roux from University of South Dakota. The BL fragment was ligated 
into a pNEBR-X1-lamin A-GFP and pNEBR-X1-progerin-GFP which inducibly express the 
fusion proteins in mammalian cells, under control of pNEBR-R1 Rheoswitch regulator plasmid. 
 Two stable cell lines expressing the GFP-BL-lamin A and GFP-BL-progerin chimeras 
were created. The expression of the chimeras was induced by incubation with 500nM of 
GenoStat for 24 hours in the presence of 50mM Biotin. Biotinylated proteins were isolated from 
cell lysates by incubation with streptavidin magnetic beads. Proteins were separated by SDS-
PAGE and sent for identification by mass spectrometry. In conclusion, we isolated multiple 
proteins that differentially associate with and/or are proximate to lamin A and progerin in vivo. 
The identification of such proteins may shed light into the mechanism by which progerin causes 
its deleterious effects. The purpose of this research is to attempt to identify the neighboring 
proteins that differentially interact with or locate near lamin A and progerin. 
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Chapter 1: INTRODUCTION 
 Proteins are vital and necessary for the continuation of human life, yet not enough is 
known about their interaction with other proteins or protein networks. It has gradually become 
more obvious that proteins can only be fully understood in the context of protein-protein 
interactions. These networks of interactions also are fundamental in understanding disease 
processes
1
, such as Hutchinson-Gilford Progeria Syndrome.  "BioID", a new approach to 
understand these interactions, was recently developed as an alternative to previous screening 
processes for protein-protein interactions
2
. Previous methods to identify protein-protein 
interactions have helped scientists understand more about these interactions, but there are 
significant drawbacks. The most common techniques for protein-protein interaction screening 
have been affinity capture screening and yeast two-hybrid systems; each has its positive and 
negative aspects. 
 Yeast two-hybrid systems are used to screen for protein-protein interactions
3
 and protein-
DNA interactions
4
 by testing for physical interactions between two proteins or a protein and 
DNA molecule
3,4
. In most eukaryotic cell transcription factors, the activating and binding sites 
can function in close proximity with each other without physical binding
5
. In the yeast two-
hybrid assay, a genetically modified yeast (lacking in certain vital nutrients) is infused with two 
separate bait and prey plasmids
6
. The bait protein's coding sequence is fused with the DNA 
binding domain (BD). The prey protein is fused into the transcription activation domain (AD). 
These vectors are then transfected into a yeast strain. If the "bait" and "prey" proteins interact, 
transcription of the gene LacZ occurs and a change in cell phenotype indicates success
3
.  
 The yeast two-hybrid system is helpful and very effective when results are achieved, 
however, some studies have shown that this system can give up to 70% false 
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positives/negatives
7
. These false readings can be caused by many reasons. The most important 
reason is that all interactions take place in vitro
2
. While in vitro, the two-hybrid system only 
takes place in the nucleus; therefore, proteins that interact outside the nucleus (but not in the 
nucleus) may be read as negative
7
. Also, assay variants over-express fusion  proteins which lead 
to false positives
7
. 
 Another method called affinity capture screening may be used to purify an enzyme 
solution or identify compounds that bind to a particular substance
8
. It usually involves a cell 
lysate solution being passed through a gel to separate out molecules in the solution. The gel is 
commonly made of agarose. This method is effective when successful, but has disadvantages. 
High-throughput genetic approaches take place in vitro, usually not having the proper machinery 
for post-translational modifications to binding partners; this can lead to incomplete data
2
. 
 A new approach was recently developed as an alternative to the previous stated screening 
processes for protein-protein interactions. Called "BioID", it is a groundbreaking method to 
screen for proteins in a natural cellular environment (in vivo)
 2
. The main goal of the BioID 
method is to identify vicinal proteins by proximity-dependent biotinylation (marking of proteins 
with biotin)
 2
. It was developed by Drs. Roux, Kim, Raida, and Burk at the University of South 
Dakota.  In the development of the BioID method, these researchers used protein lamin A and 
“biotin ligase” BirA*. 
 Lamin A is an intermediate filament protein that is encoded by the LMNA gene
9
. This 
protein is found in the nuclear lamina. Lamin A is highly insoluble and has been proven difficult 
to define via conventional approaches
9
; therefore, is an ideal candidate for BioID
2
. BirA is a 
DNA-binding biotin:protein ligase in Escherichia coli that regulates the biotinylation of a 
subunit of acetyl-CoA carboxylase and represses transcription for the biotin biosynthetic 
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operon
10
. However, BirA is too selective to use in BioID
2
.BirA*, also known as R118G, is a 
mutant of BirA. It biotinylates proteins more promiscuously than BirA
2
. 
 In BioID, a biotin ligase is fused to a protein of interest; in Dr. Roux’s experiment with 
his colleagues, they fused BirA* to lamin A
2
. The biotin ligase is then introduced into a live 
mammalian cell (Roux used HeLa cells) where it biotinylates (marks with biotin) vicinal proteins 
once the culture medium has biotin. These 
biotinylated proteins are then selectively 
isolated and identified
2
. Mass spectrometry 
is used to identify the biotinylated proteins
2
. 
BioID was used by Dr. Roux and his 
colleagues in this fashion to successfully 
biotinylate many known vicinal proteins in 
the nuclear envelope
2
 of HeLa cells and 
identified a novel protein, SLAP75
2
. 
 BioID was proven by Roux to be effective at biotinylating vicinal proteins. It has 
advantages over other common protein-protein interaction screening methods because it takes 
place in vivo. However, BioID has its weaknesses as well. It relies on the excess of biotin to be 
added to a culture in order to advance biotinylation. In theory, this can cause false positives or an 
inflated amount of biotinylated proteins
2
; however, that did not occur in Roux’s experiment. 
Also, current studies have only been in mammalian cells so it cannot be said whether or not 
BioID is useful in all types of cells. 
Figure 1. BioID Method. Adapted from Roux et al. (2012) 
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 BioID is a new approach that is powerful and effective. It is broadly accessible and can 
be used by a wide range of researchers
2
. However, it should be used as a complement to the 
current conventional methods. The method is innovative and can be used to help elucidate the 
protein-protein interactions in laminopathies such as Hutchinson-Gilford Progeria Syndrome. 
 Mutations in the LMNA gene, which encodes the nuclear filament protein lamin A, cause 
the premature aging disease Hutchinson-Gilford Progeria Syndrome. One of these mutations 
results in the expression of a mutant lamin A, with a 50-aa in-frame deletion within its C 
terminus. Our laboratory previously demonstrated that this deletion leads to a stable 
farnesylation and carboxymethylation of the mutant lamin A. These modifications cause an 
abnormal association of progerin during mitosis, induce changes in the cell cycle progression, 
and may cause DNA damage (among many other effects). 
 We employed a recently developed technique, BioID, to identify vicinal proteins by 
proximity-dependent biotinylation. This in vivo technique has an advantage over previous 
screening methods such as affinity capture screening and yeast two-hybrid systems due to its 
ability to allow proteins to interact in a natural cellular environment. We use BioID to 
experiment with lamin A∆50 (progerin) to understand its interactions in the hope of learning to 
regulate it and cure laminopathies such as Progeria. 
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Chapter 2. MATERIALS AND METHODS 
Antibodies: Mouse anti-GFP was from ABCAM (Cambridge, MA) rabbit anti-biotin ligase was 
from Hoelzel-Biotech (Germany). Secondary antibodies conjugated to Alexa-488, Alexa-565, or 
Horse radish peroxidase were from Invitrogen. Dynabeads® MyOne™ Streptavidin C1 biotin 
binding beads were also from Invitrogen. 
Plasmids: pcDNA3.1 MCS-BirA* plasmid encoding a bacterial biotin ligase (BL) was donated 
by Kyle Roux from University of South Dakota. pNEBR-X1-lamin A-GFP and pNEBR-X1-
progerin-GFP were created by Christina Bridges in Dr. Rusiñol Lab.  
Creation of biotin ligase fusion constructs: Biotin ligase/lamins fusion constructs were created 
by sub-cloning the biotin ligase open reading frame from pcDNA3.1 MCS-BirA* into either 
pNEBR-X1-lamin A-GFP and pNEBR-X1-progerin-GFP. Briefly, a biotin ligase fragment 
containing ectopic restriction enzymes sites for Not I and BamH I were generated by Polymerase 
Chain Reaction (PCR) using the following primers: 
 5’-GGAGAAATCTCCCTGAGAAGCGCAGAGAAGGGCGGCCGC-3’ 
5’-GGATCCCCCAAGCTGGCTAGCCACCATGGAACAAAAACTCATCTC-3’. For the 
restriction enzyme digestion reaction, a combination of 1µL 10x buffer, 6.5µL H20, 2µL DNA, 
and 0.5µL enzyme were combined in a microfuge tube in order. This mixture was incubated for 
1 hour at 37 ˚C.  
 The biotin ligase fragment was ligated in frame after GFP into a pNEBR-X1-lamin A-
GFP and pNEBR-X1-progerin-GFP. A Takara ligation kit was used and reaction was carried out 
for 12 h at 16˚C. E. coli cells were transformed with the products of the ligation reaction and 
plated on LB-agar plates containing 100µg/ml ampicillin. Colonies were picked after a 14 hour 
incubation at 30 ˚C. Cells from colonies were grown in 6 mL of LB media containing 100µg/mL 
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ampicillin for 12 hours at 30 ˚C.   Plasmids were purified from these or larger (500 mL) cultures 
using Qiagen plasmid purification kits according to manufacturer protocol. Constructs were 
confirmed by DNA sequencing at the Quillen College of Medicine Core Facility.   
Cell lines: To express the biotin ligase/lamin fusion proteins, we chose the Rheoswitch® 
inducible protein expression system from New England Biolabs. The RheoSwitch® Mammalian 
system allows for inducible gene expression achieved through the highly specific interaction of a 
synthetic inducer, RheoSwitch Ligand RSL1 (GenoStat, from Millipore), and a nuclear 
receptor/transcription factor. These factors are activated in the presence of GenoStat, and the 
level of gene transcription can be regulated by adjusting the concentration of GenoStat in the 
culture media. 
Creation of stable Rheoswitch® cell lines expressing GFP-BL-lamin A and GFP-BL-
progerin: pNEBR-X1-lamin A-BL-GFP and pNEBR-X1-progerin-BL-GFP plasmids were 
transfected into Rheoswitch T3T cells by using TransIT-3T3™ from Mirus Bio (Madison WI) or 
MegaTran 1.0™ from Origene (Rockville MD) in growth medium (DMEM, 10% heat 
inactivated bovine calf serum, Penicillin/Streptomycin) according to manufacturer protocol. 
After 24 hours, cells were trypsinized, diluted in a ration 1:10 and incubated in growth medium 
with 800ug/mL G418 and 200ug/mL Hygromycin for two weeks, changing medium every 3-4 
days. Colonies of resistant cells were selected, isolated, expanded, induced with GenoStat and 
checked for expression by fluorescence microscopy. Clones with various levels of expression 
were obtained and stored on liquid nitrogen. 
Inducible expression of biotin ligase-lamin fusion proteins: 10
7 
 cells were plated in 10 cm 
culture dishes and incubated in the presence of various concentrations of GenoStat for 48 hours.  
Cells were then washed twice with 5 mL of PBS and scraped in 1 mL of the ice-cold lysis buffer 
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(50 mM Tris, pH 7.4 250 mM NaCl 5 mM EDTA 50 mM NaF 1 mM Na3VO4 1% Nonidet P40 
(NP40) 0.02% NaN3) containing Halt™ (protease and phosphatase inhibitors cocktail from 
Pierce). Cells lysates were kept on ice for 10 minutes and then frozen at -80 ˚C.  
Immunoblotting: Lysates were next subjected to SDS-PAGE using the Novex electrophoresis 
system from Invitrogen according to manufacturer protocol. A constant 200 volts was used for 
approximately 45 minutes to perform the electrophoresis. Pre-stained molecular weight markers 
were ran alongside the samples. Proteins were then transferred to PVDF membranes using a 
semi-dry electro blotter, iBlot® from Invitrogen/Life Technologies. Manufacturer protocol was 
followed and the transfer time was set to seven minutes. Western Blotting with anti-GFP or anti-
biotin ligase was performed following standard procedure using primary antibodies at a dilution 
of 1:10,000 and secondary antibodies at a dilution of 1:25,000.   
Sub-cellular localization of biotin ligase-lamin fusion proteins by immunofluorescence 
3T3 Rheoswitch cells were plated on coverslips and incubated with GenoStat for 24 hours. Next, 
cells were rinsed with 1x PBS prior to fixing by incubation with 4% formaldehyde PBS for 15 
minutes at room temperature.  Cells underwent three PBS washes, and were then permeabilized 
with 0.2% Triton X-100 in PBS for five minutes on ice, washed, and blocked with 10% BSA in 
PBS for five minutes on ice.  Cells were incubated with primary antibody for one hour at room 
temperature, washed and incubated with a secondary antibody for one hour.  Dilution for mouse 
anti-GFP was 1:500 and for rabbit anti-biotin ligase 1:250 in blocking reagent. Dilution for the  
Alexa488 and Alexa565 secondary antibodies was 1:5000. Following the second incubation, 
cells were washed three times with PBS then treated with DAPI-containing anti-fade mounting 
medium to seal the stained cells between the coverslip and a microscope slide. Images were 
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obtained using an EVOS-fl automatic microscope from AMG (Life Technologies). All image 
processing (contrast stretching and image overlays) was done by the microscope software. 
BioID experimental protocol: The BioID protocol was followed as previously described by 
Roux
2
 in order to identify proteins interacting with lamin A and progerin. 
 
Fusion protein expression was induced by incubation with 500nM of Genostat for 24 hours in the 
presence of 50µM Biotin to stimulate biotinylation of vicinal proteins.  The cells were lysed in 
SDS-containing buffer to solubilize all biotinylated proteins.  The biotinylated proteins were then 
recovered with Dynabeads® MyOne™ Streptavidin C1 beads according to manufacturer 
protocol. Briefly, Lysates were incubated with the beads for 30 min at room temperature using 
gentle rotation. After separation with a magnet for 2–3 min, the coated beads were washed 4–5 
times in PBS containing 0.1% BSA and resuspended in 50 to 100 µl. Immobilized biotinylated 
proteins were released by incubation for 5 min at 90°C in nonionic water or 0.1% SDS. Samples 
Figure 4. BioID experimental protocol. Adapted from Roux et al. (2012) 
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were subjected to Sodium dodecyl sulfate polyacrylamide gel electrophoresis SDS-PAGE and 
protein containing lanes were cut into 5 mm pieces and send AB Sciex (Framingham, CT) for 
identification by MALDI-TOF mass spectrometry.  
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Chapter 3: RESULTS 
Creation of biotin ligase-lamin fusion constructs 
Biotin ligase-lamin constructs were successfully created.  
Creation of stable cell lines expressing biotin ligase-lamins fusion proteins  
Two stable 3T3 Rheoswitch cell lines were created, one containing the GFP-BL-lamin A 
chimera and another cell line containing the GFP-BL-progerin chimera. 
Inducible expression of biotin ligase-lamin fusion proteins 
To ensure that the newly created cell lines contained the inducible protein chimeras,  Western 
Blotting was used with various levels of 
GenoStat (0 nM, 250 nM, 500 nM).  The 
experimental controls without the biotin 
ligase were in 100 nM of GenoStat. As 
expected, the fusion proteins were 
expressed in the cells with the biotin ligase 
BirA* proportionally with increasing levels of GenoStat.  The fusion proteins were not expressed 
in the control cell groups. 
Sub-cellular localization of biotin ligase-lamin fusion proteins 
Immunofluorescence of  3T3 Rheoswitch 
BL-GFP-LA cells and 3T3 Rheoswitch BL-
GFP-LA∆50 cells showed the sub-cellular 
localization of biotin ligase-lamin fusion 
proteins. In the 3T3 Rheoswitch BL-GFP-
Figure 5. Protein expression in Western Blot 
Figure 6. Immunofluorescence of cells 
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LA, the fusion proteins were in the expected location of the nuclear lamina and nucleoplasma of 
the cell. In the 3T3 Rheoswitch BL-GFP-LA∆50 cells, the biotin ligase-lamin fusion proteins 
were not in the nuclear lamina but rather in aggregates inside the nucleus and perhaps the 
cytoplasm or endoplasmic reticulum membranes. 
BioID experimental protocol 
Proteins biotinylated by biotin ligase in 3T3 Rheoswitch cells expressing BL-GFP-LA and BL-
GFP-LA∆50 were identified by mass spectrometry. Most of the identified proteins are known. 
There were proteins that 
were differentially 
biotinylated by BL-GFP-
LA or BL-GFP-LA∆50. 
Examples of these 
biotinylated proteins and 
their main functions are 
seen in Figure 7.  
 
 
 
  
Figure 7. Examples of proteins differentially biotinylated by 3T3 
RheoswitchBL-GFP-LA or 3T3 RheoswitchBL-GFP-LA∆50 
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Chapter 4: DISCUSSION AND CONCLUSION 
 During this study, BioID and other techniques were used to identify neighboring proteins 
that differentially interact with or locate near lmin A and progerin. First, two new cell lines were 
successfully created with a biotin ligase BirA*: a 3T3 Rheoswitch BL-GFP-LA cell line and a 
3T3 Rheoswitch BL-GFP-LA∆50 cell line.  This was done by transfecting lamin A-Biotin 
Ligase-Green Fluorescence protein constructs and ∆50Lamin A-Biotin Ligase-Green 
Fluorescence Protein constructs into 3T3 Rheoswitch cells. To ensure the inducible system 
functioned properly, the new cell lines were induced with GenoStat and the protein expression 
levels were compared to control cells. Immunofluorescence was also used to ensure proper 
location of the expressed proteins. 
 Once these cell lines were created, the BioID method was implemented to isolate vicinal 
proteins to lamin A and progerin. The BioID method consisted of the inducible expression of the 
biotin ligase fusion protein in 3T3 Rheoswitch cells, biotinylation of vicinal proteins, lysis of 
cells in SDS-containing buffer, recovery of biotinylated proteins on stravidin-conjugated beads, 
and identification via mass spectrometry. The technique was successful in isolating and 
identifying proteins known to interact in vivo with lamin A and progerin. It was seen that most of 
these interacting proteins are known. It was also determined that there are proteins that interact 
with either lamin A or progerin, but not both. 
 Certain interesting interactions were seen that may help understand laminopathies and 
similar disease processes. For example, progerin was found to interact with a protein of the 
endoplasmic reticulum, Sec61α1; this could mean that progerin leaves the nuclear lamina and 
interacts with the walls of the endoplasmic reticulum. Also, Zmpste24, a crucial protein involved 
in the maturation of lamin A, does not interact with progerin. It is important to continue studying 
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similar protein interactions unique to progerin and lamin A in order to learn why some protein 
dysfunctions occur.  To shed more light on these processes, further studies can include 
synchronized cells in differing phases of the cell cycle such as G0, G1, S, etc.  Also, further 
exploration of the protein interactions can be accomplished through fluorescence resonance 
energy transfer (FRET), co-immunoprecipitation (Co-IP), or site directed mutagenesis.   
 In conclusion, this study is a proof of concept for identifying the neighboring proteins 
that differentially interact with or locate near lamin A and progerin. This study’s successful 
identification of near-neighbors of laminar proteins in vivo is a step on the path to completely 
understanding laminopathies and disease processes dealing with aging such as Hutchinson-
Gilford Progeria Syndrome.  
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